How personalised therapy can improve cancer treatment?

Three recent reports have offered encouraging approaches towards potentially personalized cancer drug selection.
This is largely due to the suboptimal selection of therapeutic agents and/or inevitable development of drug resistance. Thus, there is an urgent need to develop precision and personalized oncology.
Thus, there is an urgent need to develop clinically-relevant and novel in vivo models and technologies to test and/or predict drug sensitivity and the likelihood of resistance.

Copyright 2015, Chongqing Medical University. Production and hosting by Elsevier B.V. This is an open-access article under the CC BY-NC-ND license

To read the full article click here;

You must be logged in to post a comment.

Product Enquiry